Literature DB >> 22266912

A somatic EZH2 mutation in childhood acute myeloid leukemia.

T Ernst, A Pflug, J Rinke, J Ernst, U Bierbach, J F Beck, A Hochhaus, B Gruhn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22266912     DOI： 10.1038/leu.2012.16

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  Resistance revealed in acute lymphoblastic leukemia.

Authors:  Jon C Aster; Daniel J DeAngelo
Journal:  Nat Med       Date:  2013-03       Impact factor: 53.440

2.  Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemia.

Authors:  Daria G Valerio; Jenny E Katsman-Kuipers; Joop H Jansen; Lonneke J Verboon; Valerie de Haas; Jan Stary; André Baruchel; Martin Zimmermann; Rob Pieters; Dirk Reinhardt; Marry M van den Heuvel-Eibrink; C Michel Zwaan
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

3.  Gene mutations and molecularly targeted therapies in acute myeloid leukemia.

Authors:  Eleftheria Hatzimichael; Georgios Georgiou; Leonidas Benetatos; Evangelos Briasoulis
Journal:  Am J Blood Res       Date:  2013-01-17

4.  Coexistence of EZH2, NOTCH1, IL7R, and PHF6 Mutations in Adult T-cell Acute Lymphoblastic Leukemia.

Authors:  Xilian Zhou; Yan Gu; Qi Han; Mario Soliman; Chunhua Song; Zheng Ge
Journal:  Turk J Haematol       Date:  2017-07-27       Impact factor: 1.831

Review 5.  Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia.

Authors:  Younguk Sun; Bo-Rui Chen; Aniruddha Deshpande
Journal:  Front Oncol       Date:  2018-02-23       Impact factor: 6.244

Review 6.  One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies.

Authors:  Antonia Kalushkova; Patrick Nylund; Alba Atienza Párraga; Andreas Lennartsson; Helena Jernberg-Wiklund
Journal:  Epigenomes       Date:  2021-10-08

7.  Structural context of disease-associated mutations and putative mechanism of autoinhibition revealed by X-ray crystallographic analysis of the EZH2-SET domain.

Authors:  Stephen Antonysamy; Bradley Condon; Zhanna Druzina; Jeffrey B Bonanno; Tarun Gheyi; Feiyu Zhang; Iain MacEwan; Aiping Zhang; Sheela Ashok; Logan Rodgers; Marijane Russell; John Gately Luz
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

8.  SWI/SNF Subunits SMARCA4, SMARCD2 and DPF2 Collaborate in MLL-Rearranged Leukaemia Maintenance.

Authors:  V Adam Cruickshank; Patrycja Sroczynska; Aditya Sankar; Satoru Miyagi; Carsten Friis Rundsten; Jens Vilstrup Johansen; Kristian Helin
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

9.  Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms.

Authors:  Qi Zhang; Qi Han; Jie Zi; Jinlong Ma; Huihui Song; Yulu Tian; Mary McGrath; Chunhua Song; Zheng Ge
Journal:  Genes Dis       Date:  2019-05-16

Review 10.  EZH2 in Myeloid Malignancies.

Authors:  Jenny Rinke; Andrew Chase; Nicholas C P Cross; Andreas Hochhaus; Thomas Ernst
Journal:  Cells       Date:  2020-07-08       Impact factor: 6.600
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.